Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

13G Filing: Partner Fund Management and Acorda Therapeutics Inc (ACOR)

Published on July 10, 2017 at 11:15 am by Insider Monkey Staff in Hedge Funds

Page 10 of 13

Page 10 of 13 – SEC Filing

CUSIP No. 00484M106

13G

Page 10 of 13 Pages

Item 4

Ownership

A.

Partner Fund Management, L.P. and Partner Fund Management
GP, LLC

(a)

PFM and PFM-GP may be deemed to beneficially own 2,716,515 shares of Common Stock.

(b)

The number of shares PFM and PFM-GP may be deemed to beneficially own constitutes approximately 5.8%
of the Common Stock outstanding.

(c)

Number of shares as to which such person has:

(i)

sole power to vote or to direct the vote: 0

(ii)

shared power to vote or to direct the vote: 2,716,515

(iii)

sole power to dispose or to direct the disposition of: 0

(iv)

shared power to dispose or to direct the disposition of: 2,716,515

B.

Partner Investment Management, L.P. and Partner Investment Management GP, LLC

(a)

PIM and PIM-GP may be deemed to beneficially own 48,705 shares of Common Stock.

(b)

The number of shares PIM and PIM-GP may be deemed to beneficially own constitutes approximately 0.1%
of the Common Stock outstanding.

(c)

Number of shares as to which such person has:

(i)

sole power to vote or to direct the vote: 0

(ii)

shared power to vote or to direct the vote: 48,705

(iii)

sole power to dispose or to direct the disposition of: 0

(iv)

shared power to dispose or to direct the disposition of:
48,705

Follow Acorda Therapeutics Inc. (NASDAQ:ACOR)

Follow Acorda Therapeutics Inc. (NASDAQ:ACOR)

We may use your email to send marketing emails about our services. Click here to read our privacy policy.

Page 10 of 13

NASDAQ:ACOR SEC 13G Filing Partner Fund Management Acorda Therapeutics Inc (ACOR)